Table 1: Baseline characteristics.

  Total (n = 30) COVID-19 infected (n = 13) COVID-19 non-infected (n = 17) p
Sex (male) (n, %) 14 (47) 7 (54) 7 (41) 0.49
Age (years) 42 ± 13 40 ± 15 43 ± 12 0.65
Hypertension (n, %) 4 (13) 1 (8) 3 (18) 0.43
RAASi (n, %) 3 (10) 0 (0) 3 (18) 0.11
Diabetes Mellitus (n, %) 0 (0) 0 (0) 0 (0) --
Dyslipidemia (n, %) 4 (13) 1 (8) 3 (18) 0.42
Smoker (n, %) 5 (17) 2 (15) 3 (18) 0.86
Hypothyroidism (n, %) 3 (10) 1 (8) 2 (12) 0.71
Blood group
0 Positive (n, %) 10 (33) 5 (38) 5 (30) 0.11
0 Negative (n, %) 1 (3) 1 (8) 0 (0)
A positive (n, %) 12 (40) 3 (23) 9 (53)
A negative (n, %) 5 (17) 4 (31) 1 (6)
B positive (n, %) 2 (7) 0 (0) 2 (12)
Working place
Hemodialysis center (n, %) 11 (37) 3 (23) 8 (47) 0.17
Hospital (n, %) 19 (63) 10 (77) 9 (53)
Working department*
Internal medicine (n, %) 6 (20) 4 (31) 2 (12) 0.40
Nephrology (n, %) 22 (73) 8 (62) 14 (82)
Emergency (n, %) 2 (7) 1 (8) 1 (6)
Working section*       0.25
Hospitalization (n, %) 11 (37) 5 (38) 6 (35)
Dialysis (n, %) 9 (30) 3 (23) 6 (35)
Inpatient care (n, %) 3 (10) 3 (23) 0 (0)
Only on-call (n, %) 1 (3) 0 (0) 1 (6)
Various (n, %) 6 (20) 2 (15) 4 (23)
Nephrology on-call shifts (yes) (n, %)* 15 (50) 9 (70) 6 (35) 0.06
Emergency on-call shifts (yes) (n, %)* 6 (20) 5 (38) 1 (6) 0.02
No. of on-call shift hours 158 ± 81 167 ± 73 150 ± 94 0.66
Exposure time (weeks)+ 7 ± 2 8 ± 1 7 ± 3 0.23
Total exposure (hours) 237 (179-278) 240 (187-278) 237 (121-288) 0.55

Values are expressed as mean ± standard deviation or median (interquartile range).

RAASI: Renin-Angiotensin Aldosterone System Inhibitors; COVID-19: Corona virus disease-19.

*During COVID-19 pandemic. +Between 1st of March and 1st of May (maximum 9 weeks).